St. Jude Medical, Inc. (STJ) Tops Q2 EPS by 2c; Guides Q3, FY14
Get Alerts STJ Hot Sheet
Financial Fact:
Total cost of sales: 495M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q2 EPS of $1.02, $0.02 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.44 billion.
St. Jude Medical, Inc. sees Q3 2014 EPS of $0.95-$0.97, versus the consensus of $0.96. St. Jude Medical, Inc. sees Q3 2014 revenue of $1.315-1.395 billion, versus the consensus of $1.40 billion.
St. Jude Medical, Inc. sees FY2014 EPS of $3.96-$4.01, versus the consensus of $3.99. St. Jude Medical, Inc. sees FY2014 revenue of $5.64-5.76 billion, versus the consensus of $5.70 billion.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!